Published in AIDS Weekly, May 24th, 2004
The new Pharmacor study entitled "Human Immunodeficiency Virus" finds that, despite advances in therapy, the HIV drug market is constrained by social and political pressures on the pharmaceutical industry.
"HIV is a highly politically and socially charged disease; this factor has important implications for drug developers," said Aarti Raja, PhD, analyst, Decision Resources. "Pharmaceutical manufacturers have been...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.